Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eden vs Medi-Weightloss

By GLP-1 ScorecardUpdated

Eden
Site position #16

Higher score

Medi-Weightloss
Site position #134

Lower score

Score comparison

Eden has the higher recorded score — 81.6/100 to 69.6/100.

Eden grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.

Before you choose

Medi-Weightloss does not publish a semaglutide price, so its Medi-Weightloss review sets out what it does disclose, while the Eden review explains the conditions attached to Eden's figure. The semaglutide cost page compares published rates across the field. Ask Medi-Weightloss for a written total before treating either one as the cheaper choice.

If neither one fits, Eden vs MediRX and Effecty vs Medi-Weightloss compare each of them with another graded program, and the list of alternatives to Eden ranks the programs closest to Eden on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueEden +31
85
54
Dose & formulationEden +21
86
65
Clinical oversightMedi-Weightloss +32
55
87
Labs & monitoringEden +2
92
90
FulfillmentEden +28
93
65
Contract termsEden +35
90
55
Eden · top barMedi-Weightloss · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEdenMedi-Weightloss
WeighScore81.6/10069.6/100
GradeB−C
Site position#16#134
SemaglutideAdvertised $99/mo bundle; linked membership terms conflict—confirm checkoutMedication-inclusive price not established; confirm clinic quote
TirzepatideAdvertised $129/mo bundle; linked membership terms conflict—confirm checkoutMedication-inclusive price not established; local first-month offers vary
CoverageAll 50 statesClinic-specific; telehealth at participating locations
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Eden

Site position #16 · B−

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Strengths

  • Current compounded offer includes medication and support
  • Homepage also advertises branded prescription pathways; eligibility and cost require confirmation
  • Named pharmacy operation and partner network can be investigated

What to consider

  • Linked membership terms describe a separate fee model
  • Landing-page warranty and terms use different thresholds and conditions
  • FDA warning history remains relevant; a new offer does not establish resolution
Medi-Weightloss

Site position #134 · C

Strengths

  • Describes recurring clinic visits, nutrition guidance and body-composition reviews.
  • Lists branded Wegovy, Zepbound and Saxenda alongside compounded injection options, subject to provider assessment.
  • Publishes a pharmacy network; the provider chooses the dispensing assignment.
  • Insurance and HSA/FSA options are described, with coverage dependent on location and plan.

What to consider

  • The local $199 initial visit and $199 starting program are not a national branded-medication price.
  • Medication, labs, supplements and other services can cost extra; get the complete local quote.
  • Early visits can be weekly, and telehealth is not assured at every clinic.
  • The selected membership, prepayment, renewal and refund agreement still needs confirmation.

Featured provider

Eden

Eden scores 81.6/100 (B−). Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.

Commercial relationships affect this placement. The score comparison above is separate.

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard